Down syndrome is, in about 95% of cases, the result of non- disjunction of chromosome 21 in oogenesis or spermatogenesis (trisomy 21). The gold standard laboratory test to diagnose a fetus with Down syndrome is karyotype analysis by chorionic villus sampling or amniocentesis. The latter are invasive techniques associated with a low risk of fetal loss. A non-invasive alternative, and therefore not associated with any risk to the fetus, is the application of tests that estimate risk by combining information from ultrasound examination and/or biochemical examination of maternal blood with maternal age and gestational age. These tests provide the result in a number; if this value exceeds a specific cut-off, the test will be positive, and the woman may undergo more invasive investigations, such as amniocentesis and villocentesis. In particular, ultrasonography evaluates nuchal translucency, which is the measurement of the thickness of the subcutaneous tissue at the nape of the neck of the fetus, that is, the space between the skin and the spine. The greater the thick ness of nuchal translucency, the greater the probability that the fetus has Down’s syndrome. Biochemical examinations, on the other hand, are based on the evaluation of serum markers such as human chorionic gonadotropin (total or free beta fraction, hCG), pregnancy-associated plasma protein A (PAPP-A), alpha-fetoprotein (AFP), unconjugated estriol (uE3), and inhibin A. Table 1 shows the main tests available for assessing the risk of Down syndrome. It is important to note that a positive result from these tests does not indicate that the fetus will have Down syndrome.

Table1. Tests to assess Down syndrome risk

PAPP-A is a glycoprotein of placental origin, produced mainly in the syncytiotrophoblast.

AFP is a glycoprotein secreted first by the yolk sac and then by the fetus’s liver It has the same functions as albumin; immediately after birth, its concentrations progressively decrease until it is absent. AFP can cross the placenta and reach the maternal circulation, where its levels will be directly proportional to those in the fetal circulation.

Estriol is a steroid hormone produced in unconjugated form exclusively during pregnancy by the placenta and fetal organs: the fetal adrenal glands produce dehydroepiandrosterone sulfate (DHEA-S), which is hydroxylated by the fetal liver to 16-hydroxy-DHEA-S and subsequently metabolized by the placenta to form unconjugated estriol. The uE3 secreted by the placenta then passes into the maternal circulation; after conjugation in the liver, it is subsequently eliminated in the urine. The levels of uE3 increase in the maternal circulation as pregnancy progresses, especially in the third trimester; they are an index of the functionality of the fetoplacental unit.

Inhibin A is a dimeric glycoprotein produced by the corpus luteum and placenta during pregnancy. Generally, in the circulation of a mother of a fetus with Down’s syndrome, there should be, compared to a normal fetus, an increase in the levels of hCG and inhibin A and a decrease in the levels of PAPP-A, uE3, and AFP.

اخر الاخبار

اخبار العتبة العباسية المقدسة

قسم الشؤون الفكرية يقيم مهرجان الماء المعين السنوي الثالث في بغداد

على هامش المؤتمر التمهيدي لألفية الحوزة العلمية.. الهيأة العليا تقيم جلسة حوارية عن تراث الشيخ الطوسي

العتبة العباسية المقدسة تستعد لإقامة حفل التكليف الشرعي لتلميذات مدارس كربلاء

لليوم الثاني.. قسم التطوير يواصل تقديم دورة إعداد المدربين (TOT) لملاكات مديرية تربية كربلاء

المزيد

الآخبار الصحية

اللوز.. "كنز صحي" يحمي دماغك

رفض اعتماد "لقاح موديرنا" للإنفلونزا.. وكشف الأسباب ؟

تحذير طبي من مرض شائع يزيد خطر الإصابة بنوعين من السرطان

الإنفلونزا لا تضرب الرئة فقط.. دراسة تكشف خطرها على القلب

المزيد

الآخبار التكنلوجية

سلاح طبي في ساحات الحرب.. رذاذ يوقف النزيف خلال ثانية !

مايكروسوفت تدق ناقوس الخطر وتحذر من "الذكاء الاصطناعي الخفي"

الإمارات تطلق شراكة عالمية مع ستارلينك لإتاحة التعليم الرقمي

"أوبن إيه آي" تختبر عرض الإعلانات داخل محادثات chatgpt

المزيد

مواضيع ذات صلة

Pharmacogenomics

Monogenic Diseases Show One of Three Patterns of Inheritance

Tumor Suppressor Genes in Autosomal Dominant Cancer Syndromes

Activated Oncogenes in Hereditary Cancer Syndromes

Genetic Basis of Cancer

Conditional Mutations Can Be Used to Study Essential Genes in Yeast

Segregation of Mutations in Breeding Experiments Reveals Their Dominance or Recessivity

Recessive and Dominant Mutant Alleles Generally Have Opposite Effects on Gene Function

Genes and Environment in Development

Gene Therapy

The Genetics of mtDNA Disease

The APOE Gene Is an Alzheimer Disease Susceptibility Locus